The Evolving Practice of Cardiovascular Precision Medicine
Registration will open in January 2021. To receive a notification when registration opens, please click here.
Statement of Need/Overview
The advent of high throughput technologies (genomics, metabolomics, proteomics) and big data analytics (machine learning, artificial intelligence), as well as the expansion of digital health tools, has ushered in the era of precision medicine in cardiovascular disease. The concept of personalizing therapies to maximize benefits and minimize risk for patients is now within reach. While healthcare providers have overwhelmingly expressed interest in innovation and the transformation of medicine, most have had little to no exposure to the data, platforms, methods and clinical applications that form the foundation of Precision Medicine. Join us for this course and equip yourself with foundational and operational knowledge of precision medicine and how to apply techniques to your clinical and research settings.
The overall goal is to equip cardiovascular providers with the core knowledge and skills to understand and apply evidenced-based genomic medicine and digital technologies to patients at risk for and with established cardiovascular disease and to recognize the current limitations of each approach. Learners will acquire the knowledge to implement precision medicine strategies in clinical practice, research, and quality improvement initiatives and use applications of precision medicine in cardiovascular genomics, cardiac imaging, and clinical decision support. The focus of this course is on three key areas that are rapidly growing in clinical applications:
- Genomic medicine in cardiovascular disease prevention and management
- Machine learning applications in cardiovascular imaging
- Integration of digital health tools for personalization of cardiovascular care
The target audience is cardiovascular care providers (physicians, advanced practice providers, and nurses) interested in implementing precision medicine applications in their practice and translational cardiovascular researchers without prior expertise in omics and big data analytics, interested in expanding their skill set in those areas.
Regina Druz, MD, FACC
Director, Integrative Cardiology
St. Francis Hospital - New York
Akl C. Fahed, MD, MPH
Massachusetts General Hospital
Genomic & Precision Medicine Researcher
Harvard Medical School
Geoffrey Ginsburg, Md, PhD, FACC
Professor and Director, Duke Center for Applied Genomics and Precision Medicine
Duke University School of Medicine
Evan Muse, MD, PhD, FACC
Associate Program Director for Research, Division of Cardiovascular Diseases
Lead Cardiovascular Genomics
Scripps Research Translational Institute
Partho Sengupta, MD, FACC
Chief of Cardiology
West Virginia University Heart and Vascular Institute
Disclosure/Conflict of Interest Statement
As a provider jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity and scientific rigor in all of their directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors, in a position to control the content are required to disclose to the audience all relevant financial relationships he/she and/or his/her spouse or domestic partner may have, occurring within the past 12 months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investigational.
ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the education activity.
ACCF assesses conflicts of interest (COI) with its faculty, planners, managers, staff and other individuals who are in a position to control the content of certified activities. All relevant potential conflicts of interest that are identified are thoroughly vetted by course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup (ACWG) through a process that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations.
Please note ACCF staff and the ACWG members involved with this activity have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This course has been approved for AMA PRA Category 1 Credits™.
Maintenance of Certification (MOC) Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.